Molecular Virology Core

分子病毒学核心

基本信息

项目摘要

The overall objectives of UMass CFAR Molecular Virology Core facility are: (1) to maintain and continuously monitor the safety operations of a BSL3- and a BSL2-containment facility that will support a safe and biohazard-free environment for work with pathogenic primate immunodeficiency viruses; (2) to provide resources and services to participating CFAR investigators for their ongoing virus-related projects; and (3) to function as a central site where collaborations amongst UMass CFAR investigators is fostered. The Core services include: (1) assays for isolation, titration, phenotypic and genotypic characterization of virus; (2) providing a centralized source and repository for primary T-cells, macrophages & T-cell lines; and (3) molecular detection/diagnostic assays including qualitative and quantitative RNA and DNA-PCR for viral genomes & state of the art, cutting edge LightCycler-based PCR assays for real-time detection and quantitation of HIV-1. The Molecular Virology Core facility, in conjunction with UMass CFAR-Clinical and Molecular Biology Core facilities, uphold the mission of UMass CFAR by providing standardized and centralized routine research techniques and reagents; reducing expenditure by eliminating duplication of effort & by efficient use of personnel; and fostering new collaborative projects and grants. The Molecular Virology Core is also committed to provide educational & training opportunities to CFAR investigators and students/fellows in working within BSL3 containment facility, in developing new molecular virology assays, in BSL3 Certification, and in PCR Certification. Details of the Molecular Virology Core facility, its location, its functions, the services provided are all available on the UMass CFAR Molecular Virology Core website (www.umassmed.edu/cfar/viroloavcore).
UMass CFAR分子病毒学核心设施的总体目标是:(1)维持和持续

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MOHAN SOMASUNDARAN其他文献

MOHAN SOMASUNDARAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MOHAN SOMASUNDARAN', 18)}}的其他基金

CORE--BIOHAZARD CONTROL
核心——生物危害控制
  • 批准号:
    6353462
  • 财政年份:
    2000
  • 资助金额:
    $ 27.38万
  • 项目类别:
CORE--BIOHAZARD CONTROL
核心——生物危害控制
  • 批准号:
    6201408
  • 财政年份:
    1999
  • 资助金额:
    $ 27.38万
  • 项目类别:
CORE--BIOHAZARD CONTROL
核心——生物危害控制
  • 批准号:
    6100201
  • 财政年份:
    1998
  • 资助金额:
    $ 27.38万
  • 项目类别:
MOLECULAR DETERMINANTS OF CELL DEATH BY HIV1
HIV1 导致的细胞死亡的分子决定因素
  • 批准号:
    2876549
  • 财政年份:
    1998
  • 资助金额:
    $ 27.38万
  • 项目类别:
Molecular Virology Core
分子病毒学核心
  • 批准号:
    8310052
  • 财政年份:
  • 资助金额:
    $ 27.38万
  • 项目类别:
Molecular Virology Core
分子病毒学核心
  • 批准号:
    7656702
  • 财政年份:
  • 资助金额:
    $ 27.38万
  • 项目类别:
Molecular Virology Core
分子病毒学核心
  • 批准号:
    8109191
  • 财政年份:
  • 资助金额:
    $ 27.38万
  • 项目类别:
Molecular Virology Core
分子病毒学核心
  • 批准号:
    8440952
  • 财政年份:
  • 资助金额:
    $ 27.38万
  • 项目类别:
Molecular Virology Core
分子病毒学核心
  • 批准号:
    7927081
  • 财政年份:
  • 资助金额:
    $ 27.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了